Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMITRIPTYLINE Cause Transient ischaemic attack? 11 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Transient ischaemic attack have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 0.1% of all adverse event reports for AMITRIPTYLINE.

11
Reports of Transient ischaemic attack with AMITRIPTYLINE
0.1%
of all AMITRIPTYLINE reports
0
Deaths
10
Hospitalizations

How Dangerous Is Transient ischaemic attack From AMITRIPTYLINE?

Of the 11 reports, 10 (90.9%) required hospitalization, and 7 (63.6%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does AMITRIPTYLINE Cause?

Toxicity to various agents (3,001) Drug ineffective (2,344) Completed suicide (1,678) Off label use (1,588) Pain (1,300) Fall (1,216) Hypotension (1,205) Drug abuse (1,116) Dizziness (1,041) Constipation (1,035)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which AMITRIPTYLINE Alternatives Have Lower Transient ischaemic attack Risk?

AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE AMITRIPTYLINE vs AMIVANTAMAB AMITRIPTYLINE vs AMIVANTAMAB-VMJW AMITRIPTYLINE vs AMLODIPINE AMITRIPTYLINE vs AMLODIPINE BESILATE

Related Pages

AMITRIPTYLINE Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack AMITRIPTYLINE Demographics